Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Sep;13(9):1009-12.
doi: 10.1586/14737140.2013.825424.

Toward a cure for chronic lymphocytic leukemia: an attack on multiple fronts

Alexey V Danilov  1 , Ryan S Soderquist, Darcy J P Bates, Alan Eastman
Affiliations
Editorial

Toward a cure for chronic lymphocytic leukemia: an attack on multiple fronts

Alexey V Danilov et al. Expert Rev Anticancer Ther. 2013 Sep.
No abstract available

PubMed Disclaimer

References

    1. Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer. 2001;92(5):1325–1330. - PubMed
    1. Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood. 2008;111(10):4916–4921. - PubMed
    1. Danilov AV, Danilova OV, Klein AK, Huber BT. Molecular pathogenesis of chronic lymphocytic leukemia. Curr Mol Med. 2006;6(6):665–675. - PubMed
    1. Vogler M, Butterworth M, Majid A, et al. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood. 2009;113(18):4403–4413. Describes lymph node-mimicking coculture system. Implicates upregulation of BCLX and BFL1/BCL2A1 in resistance to ABT-737. - PubMed
    1. Tromp JM, Tonino SH, Elias JA, et al. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering. Oncogene. 2010;29(36):5071–5082. Describes a dichotomy in NF.B signaling under CD40/TLR9 signaling in CLL. - PubMed

Publication types

MeSH terms